Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category, whereas...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Establishing a New Stem Cell Crossmatch Assay to Assess the Impact of HLA-Specific Antibodies on CD34+ Stem Cells.

HLA·2026
Same author

The Use of Prisms in the Management of Nystagmus: A Case Series and Literature Review.

Investigative ophthalmology & visual science·2026
Same author

Foodborne sources of antimicrobial-resistant Escherichia coli in community-acquired urinary tract infections in Bangladesh.

Communications medicine·2026
Same author

QIM26-308: Operationalizing Equity in Oncology: Developing Dashboards for Evaluation of Racial and Ethnic Disparities Using Claims-Based Measures.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

Analysis of endoscopic orbital decompression with and without navigation for thyroid eye disease.

Orbit (Amsterdam, Netherlands)·2026
Same author

QIM26-308: Operationalizing Equity in Oncology: Developing Dashboards for Evaluation of Racial and Ethnic Disparities Using Claims-Based Measures.

Journal of the National Comprehensive Cancer Network : JNCCN·2026

Related Experiment Video

Updated: Jun 28, 2026

Detecting Abnormalities in Choroidal Vasculature in a Mouse Model of Age-related Macular Degeneration by Time-course Indocyanine Green Angiography
10:24

Detecting Abnormalities in Choroidal Vasculature in a Mouse Model of Age-related Macular Degeneration by Time-course Indocyanine Green Angiography

Published on: February 19, 2014

Aniridia: current pathology and management.

Helena Lee1, Rizwana Khan, Michael O'Keefe

  • 1Department of Paediatric Ophthalmology, Children's University Hospital, Dublin, Ireland.

Acta Ophthalmologica
|October 22, 2008
PubMed
Summary
This summary is machine-generated.

Aniridia, a rare eye condition caused by PAX6 gene mutations, affects multiple ocular structures. Current treatments for aniridia-associated keratopathy and glaucoma are limited, highlighting the need for more effective therapies.

More Related Videos

Iris Fixation via External Pentagram Suturing
05:22

Iris Fixation via External Pentagram Suturing

Published on: May 5, 2022

Related Experiment Videos

Last Updated: Jun 28, 2026

Detecting Abnormalities in Choroidal Vasculature in a Mouse Model of Age-related Macular Degeneration by Time-course Indocyanine Green Angiography
10:24

Detecting Abnormalities in Choroidal Vasculature in a Mouse Model of Age-related Macular Degeneration by Time-course Indocyanine Green Angiography

Published on: February 19, 2014

Iris Fixation via External Pentagram Suturing
05:22

Iris Fixation via External Pentagram Suturing

Published on: May 5, 2022

Area of Science:

  • Ophthalmology
  • Genetics
  • Developmental Biology

Background:

  • Aniridia is a rare genetic disorder affecting the entire eye, stemming from PAX6 gene mutations.
  • It is linked to syndromes like WAGR syndrome and causes various ocular abnormalities.
  • PAX6 mutations disrupt corneal cell characteristics and stem cell function, leading to a fragile cornea and aniridia-associated keratopathy (AAK).

Purpose of the Study:

  • To review the genetic basis, pathology, and current management strategies for aniridia.
  • To discuss the challenges in treating aniridia-associated complications like AAK and glaucoma.
  • To explore potential therapeutic approaches for this complex panocular disorder.

Main Methods:

  • Review of existing literature on aniridia genetics and pathology.
  • Analysis of clinical manifestations and associated syndromes.
  • Evaluation of current and emerging treatment options for ocular complications.

Main Results:

  • PAX6 mutations lead to corneal fragility (AAK), glaucoma, cataracts, and optic nerve hypoplasia.
  • Aniridia is a profibrotic condition, complicating surgical interventions like penetrating keratoplasty.
  • The Boston keratoprosthesis shows promise for AAK, and guarded filtration surgery for glaucoma.

Conclusions:

  • Effective treatments for aniridia remain challenging due to its complex pathology and profibrotic nature.
  • While some interventions show promise for specific complications, a comprehensive therapeutic strategy is still needed.
  • Further research into the genetics and pathophysiology of aniridia is crucial for developing better treatments.